Radboud University Medical Center: Sepsis trials
The registry lists 16 Sepsis studies with Radboud University Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 5Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study on How the Immune System Responds to Sepsis and Its Long-term EffectsRecruitingNCT07273344
- Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human EndotoxemiaRecruitingNCT06624436Phase 4
- Determining the Fingerprint of Endotoxin ToleranceCompletedNCT06801873Not applicable
- The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor CellsCompletedNCT05570643Not applicable
- Assessing the Effects of CytoSorb Hemoperfusion on the Development on ImmunoparalysisCompletedNCT04643639Phase 3
- Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.Status unknownNCT04470973
- Continuous Monitoring on the General WardCompletedNCT02933307Not applicable
- Effects of BCG on Immune ResponseCompletedNCT02085590Phase 2/3
- In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR IICompletedNCT01766414Phase 3
- The Effects of Interferon-gamma on Sepsis-induced ImmunoparalysisCompletedNCT01649921Phase 3
- The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human EndotoxemiaCompletedNCT01374711Not applicable
- The Effects of Atazanavir-induced Hyperbilirubinemia During Human EndotoxemiaCompletedNCT00916448Not applicable
- In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human EndotoxemiaCompletedNCT00785018Not applicable
- Anti-inflammatory Effects of GTS-21 After LPSCompletedNCT00783068Not applicable
- Effects of Alkaline Phosphatase on Renal Function in Septic PatientsCompletedNCT00457613Phase 2
- The AOT (Acridine Orange and Taurolidine) TrialCompletedNCT00321165Phase 3